Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 97,497 ordinary shares between July 27 and July 31, spending a total of approximately €2.4 million under a program announced in June. The average price paid during the period was €24.48 per share, with transactions occurring across multiple trading venues including Euronext Amsterdam and Nasdaq.
Key figures
- Avg price eur
- 24.48
- Total cost eur
- €2,386,239.93
- Shares repurchased
- 97497
- Treasury shares held
- 704216
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.